Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 16.282\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: COCCCN1C(=O)c2ccc(C(=O)Nc3ccccc3Cl)cc2C1=O
b: C#CCC(NC(=O)c1ccc(C(F)(F)F)cc1)C(=O)NCCC
Answer: b. C#CCC(NC(=O)c1ccc(C(F)(F)F)cc1)C(=O)NCCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCC(NC(=O)c1ccc(C(F)(F)F)cc1)C(=O)NCCC
C#CCC(NC(=O)c1ccc(C(F)(F)F)cc1)C(=O)NCCC
N-[1-oxo-1-(propylamino)pent-4-yn-2-yl]-4-(trifluoromethyl)benzamide